NCT06033157

Brief Summary

The goal of this clinical trial is to investigate if physiotherapist supervised training improves neuromuscular control in patients suffering from traumatic anterior shoulder instability. The main question(s) it aims to answer are:

  • Does physiotherapist supervised training improve shoulder neuromuscular control
  • Does physiotherapist supervised training prevent recurring shoulder dislocations
  • Is physiotherapist supervised training as good as surgery in improving shoulder neuromuscular control Participants will be randomised to either a training group or a no-training group. Participants in the training group will undergo a 12 week training-program supervised by a physiotherapist. Participants in the no-training group will receive a consultation with a shoulder surgeon, where information and general advice regarding the shoulder injury is provided. Researchers will compare the training group to the no-training group to see if physiotherapist supervised training improves shoulder neuromuscular control in patients with traumatic anterior shoulder instability. The training group will also be compared to a historic group of patients with traumatic anterior shoulder instability, who underwent arthroscopic surgery.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Nov 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Nov 2023Apr 2027

First Submitted

Initial submission to the registry

August 16, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

November 7, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Expected
Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

1.9 years

First QC Date

August 16, 2023

Last Update Submit

April 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Neuromuscular control - Shouldersway

    \- Shoulder sway. Measured as sway-length (in millimeter).

    Will be tested prior to intervention and 3 and 6 months after the beginning of the intervention

Secondary Outcomes (8)

  • Clinical examination - Shoulder instability

    Will be tested prior to intervention and 3 and 6 months after the beginning of the intervention

  • Clinical examination - Shoulder range of motion

    Will be tested prior to intervention and 3 and 6 months after the beginning of the intervention

  • Strength measure

    Will be tested prior to intervention and 3 and 6 months after the beginning of the intervention

  • Apprehension measure

    Will be tested prior to intervention and 3 and 6 months after the beginning of the intervention

  • Patient-reported outcome measures

    Will be tested prior to intervention and 3, 6, 12 and 24 months after the beginning of the intervention

  • +3 more secondary outcomes

Study Arms (2)

Training

ACTIVE COMPARATOR

A 12 week physiotherapist supervised training program

Behavioral: Physiotherapist supervised training

No-training

NO INTERVENTION

A short consultation with a designated orthopedic surgeon and a folder with general advice on how to avoid further dislocations and to relieve pain from the shoulder.

Interventions

A 12 week physiotherapist supervised training program. The patient will receive supervision by a physiotherapist 6 times during the intervention period. The patient is strongly encouraged to do the assigned training protocol at home 3 times a week. The supervised physiotherapy consists of introduction, review and progression of the assigned exercises. In addition, the patient will receive education and guidance in daily use of the arm and appropriate load on the shoulder.

Training

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-40 years.
  • Unilateral traumatic anterior shoulder instability.
  • Willingness to adhere to the study protocol, herein attend follow-up.
  • Ability to speak, read, and understand Danish.
  • Ability to give written informed consent.

You may not qualify if:

  • Instability in the opposite shoulder.
  • Off-track lesion.
  • For both shoulders: Former or planned surgery.
  • For both shoulders: posterior, multi-directional or atraumatic instability.
  • For both shoulders: traumatic rotator cuff or biceps tendon tear.
  • For both shoulders: traumatic fracture of proximal humerus (other than Hill-Sachs lesion), clavicula, scapula (other than glenoid) or dislocation of sternoclavicular or acromioclavicular joints.
  • For both shoulders: atraumatic shoulder pathologies (e.g. frozen shoulder, symptomatic osteoarthritis of the shoulder or acromioclavicular joints, acute tendinitis calcarean).
  • Pregnancy.
  • Terminal illness or severe medical illness: ASA score ≥3.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sports Orthopedic Research Center - Copenhagen (SORC-C), Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre

Hvidovre, Capital Region, 2650, Denmark

Location

Study Officials

  • Kristine R Andreasen, MD

    Copenhagen University Hospital, Hvidovre

    PRINCIPAL INVESTIGATOR
  • Kristoffer W Barfod, MD, PhD

    Copenhagen University Hospital, Hvidovre

    STUDY CHAIR
  • Kristoffer W Barfod, MD, PhD

    Copenhagen University Hospital, Hvidovre

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 16, 2023

First Posted

September 13, 2023

Study Start

November 7, 2023

Primary Completion

October 1, 2025

Study Completion (Estimated)

April 1, 2027

Last Updated

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations